Global Antigen Skin Test Market Size By Type (Fungal infection, Bacterial infections), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

lobal Antigen Skin Test Market Report Description

The Global Antigen Skin Test Market was valued at USD 980 million in 2023 and is projected to reach USD 1.85 billion by 2031, growing at a CAGR of 8.4% during the forecast period (2023–2031).

The growth is primarily driven by the increasing prevalence of infectious diseases such as tuberculosis (TB), leprosy, and fungal infections, along with the rising awareness of early disease detection. Antigen skin tests are widely used for diagnosing delayed-type hypersensitivity reactions by introducing specific antigens intradermally. Their simplicity, cost-effectiveness, and high reliability make them a preferred diagnostic tool in hospitals, clinics, and public health programs.

The market is also benefiting from growing investments in diagnostic infrastructure, rising public health initiatives in developing nations, and the introduction of novel antigen formulations to improve test specificity and sensitivity.

Drivers

✅ Increasing Prevalence of Tuberculosis and Other Infectious Diseases

With TB remaining one of the top infectious killers worldwide, antigen skin tests continue to play a crucial role in early screening and diagnosis. WHO’s initiatives for global TB eradication are further boosting the adoption of these tests.

✅ Rising Public Health Programs and Awareness

Governments and NGOs are conducting mass screening programs for infectious diseases in endemic regions, significantly driving the demand for affordable antigen-based diagnostic tests.

✅ Technological Advancements in Diagnostic Solutions

Innovations in antigen formulations, improved intradermal delivery methods, and integration with digital reporting tools are enhancing test accuracy and convenience, supporting market expansion.

Restraints

❌ Limited Specificity in Certain Conditions

While antigen skin tests are highly useful for screening, they may have limited specificity in immunocompromised patients or those vaccinated with certain antigens, leading to false positives or negatives.

❌ Availability of Advanced Molecular Diagnostics

The emergence of more sophisticated diagnostics like interferon-gamma release assays (IGRAs) and PCR-based tests is creating competition, especially in high-income countries.

Opportunities

💡 Emerging Markets with High Infectious Disease Burden

Countries in Asia-Pacific and Africa with a high prevalence of TB, fungal infections, and parasitic diseases present significant growth opportunities for antigen skin test manufacturers.

💡 Development of Next-Generation Antigen Test Kits

Manufacturers are investing in the development of next-generation antigen tests with higher accuracy, stability, and ease of use, creating new revenue streams.

💡 Integration with Digital Health Platforms

Linking antigen skin test results with mobile health apps and telemedicine platforms could enhance remote disease monitoring and reporting.

Market by System Type Insights

Tuberculin Skin Test (TST) held the largest market share in 2023, widely used for TB screening in both high-burden and low-burden countries.

Candidin and Trichophytin Skin Tests are expected to witness moderate growth, driven by rising fungal infection awareness.

Novel custom antigen panels are emerging for research and clinical trials in autoimmune and allergic conditions.

Market by End-Use Insights

Hospitals & Clinics accounted for over 55% of the market in 2023, as most tests are administered in a clinical setting.

Public Health Programs represent a rapidly growing segment, especially in TB-endemic countries where community-based screening initiatives are expanding.

Research Institutes also contribute significantly to demand due to the increasing use of antigen tests in immunological research.

Market by Regional Insights

Asia-Pacific dominated the market in 2023 due to a high prevalence of TB and other infectious diseases, alongside large-scale government screening initiatives.

Africa is expected to experience the highest CAGR during the forecast period, driven by international funding for infectious disease control.

North America and Europe maintain steady demand, supported by TB control programs among high-risk populations and refugees.

Competitive Scenario

Key players in the Global Antigen Skin Test Market include:

Sanofi

Serum Institute of India

Thermo Fisher Scientific Inc.

Statens Serum Institut

Bio-Rad Laboratories, Inc.

Span Diagnostics Ltd.

GlaxoSmithKline (GSK)

These companies focus on expanding their product portfolios, enhancing test accuracy, and forming partnerships with public health organizations to strengthen their market presence.

Recent developments include:

2023: Sanofi launched an enhanced tuberculin antigen formulation with improved stability for tropical climates.

2024: Thermo Fisher Scientific partnered with global TB control programs to supply large-scale antigen test kits in Africa.

2025: Serum Institute of India introduced a cost-effective multi-antigen skin test panel for simultaneous detection of fungal and bacterial infections.

Scope of Work – Global Antigen Skin Test Market

Key Market Developments

March 2023: Sanofi announced the development of a long-lasting tuberculin antigen formulation suitable for mass screening in resource-limited settings.

July 2024: Bio-Rad Laboratories introduced an automated skin test reading device for improved test interpretation in hospitals.

January 2025: Serum Institute partnered with WHO to distribute low-cost antigen skin tests across South Asia.

FAQs

1️⃣ What is the current market size of the Global Antigen Skin Test Market?

The market was valued at USD 980 million in 2023.

2️⃣ What is the major growth driver of the Global Antigen Skin Test Market?

The increasing prevalence of infectious diseases like TB and rising public health initiatives are key drivers.

3️⃣ Which is the largest region during the forecast period in the Global Antigen Skin Test Market?

Asia-Pacific is expected to remain the largest region due to high disease burden and government programs.

4️⃣ Which segment accounted for the largest market share in the Global Antigen Skin Test Market?

The Tuberculin Skin Test (TST) segment dominated the market in 2023.

5️⃣ Who are the key market players in the Global Antigen Skin Test Market?

Key players include Sanofi, Thermo Fisher Scientific, Serum Institute of India, Bio-Rad Laboratories, and GSK.

Would you like me to also generate an infographic-style summary or a structured PDF for better presentation?